Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 950 of 2873 entries
View as:

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04751396 Org: User:
Start: 04/20/22 End: 02/02/27 Due: 02/02/28

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03025256 Org: User:
Start: 05/02/18 End: 12/30/25 Due: 12/30/26

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02701673 Org: User:
Start: 06/30/16 End: - Due: -

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00041782 Org: User:
Start: 10/31/00 End: 01/31/05 Due: 01/31/06

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05776979 Org: User:
Start: 08/17/23 End: 12/31/27 Due: 12/31/28

GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)

Phase: N/A Priority: Normal
NCT ID: NCT05131945 Org: User:
Start: 12/10/18 End: 09/10/24 Due: 09/10/25

Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113334 Org: User:
Start: 04/30/05 End: 03/31/08 Due: 03/31/09

Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT04239976 Org: User:
Start: 04/04/19 End: 03/18/22 Due: 03/18/23

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT06420206 Org: User:
Start: 05/14/24 End: 02/02/27 Due: 02/02/28

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase: N/A Priority: Normal
NCT ID: NCT06576037 Org: User:
Start: 10/31/24 End: 06/01/29 Due: 06/01/30

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Phase: N/A Priority: Normal
NCT ID: NCT04729725 Org: User:
Start: 02/09/21 End: 12/02/22 Due: 12/02/23

Risk Perception Among Quitting Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00384696 Org: User:
Start: 02/10/06 End: 12/31/20 Due: 12/31/21

Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients

Phase: N/A Priority: Normal
NCT ID: NCT05290402 Org: User:
Start: 02/28/22 End: 12/31/26 Due: 12/31/27

ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03725436 Org: User:
Start: 01/24/19 End: 07/26/25 Due: 07/26/26

Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)

Phase: N/A Priority: Normal
NCT ID: NCT00525655 Org: User:
Start: 08/31/07 End: 03/18/21 Due: 03/18/22

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Phase: N/A Priority: Normal
NCT ID: NCT02203136 Org: User:
Start: 06/25/14 End: 05/16/19 Due: 05/16/20

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06389721 Org: User:
Start: 07/16/24 End: 01/31/27 Due: 01/31/28

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04151082 Org: User:
Start: 10/16/19 End: 07/31/25 Due: 07/31/26

Study of SB939 in Subjects With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01200498 Org: User:
Start: 11/30/10 End: 11/30/12 Due: 11/30/13

A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT00349596 Org: User:
Start: 07/31/06 End: 10/31/14 Due: 10/31/15

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT05118854 Org: User:
Start: 03/30/22 End: 10/20/25 Due: 10/20/26

Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04047797 Org: User:
Start: 08/28/19 End: 04/11/25 Due: 04/11/26

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002832 Org: User:
Start: 08/31/95 End: 03/31/02 Due: 03/31/03

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

Phase: N/A Priority: Normal
NCT ID: NCT05056844 Org: User:
Start: 04/15/21 End: 04/30/27 Due: 04/30/28

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Phase: N/A Priority: Normal
NCT ID: NCT05038384 Org: User:
Start: 12/03/20 End: 03/30/23 Due: 03/30/24